 This study demonstrated the potential of immunogenius as a diagnostic tool for lymphoid neoplasms. It showed high precision rates in most B-cell lymphomas and generally comparable performance in T-cell lymphomas. However, some cases had atypical IHC profiles or lack specific markers, which resulted in lower precision rates. Additionally, overlapping IHC profiles of similar diseases may have contributed to the low precision rates. Despite these limitations, the authors concluded that immunogenius can be used for diagnosing lymphoid neoplasms with a generally acceptable hit rate in a nationwide dataset. This article was authored by Jim Shitab-Doolgauffer, Kyung-Jeon Seo, Hi-Rae Young, and others.